Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9CNS 5Thoracic 4Lymphoid 3Head & Neck 3Other hematologic neoplasm 2Genitourinary 2Dermatologic 2Sarcoma 1Gynecologic 1

Conditions

Prostatic Neoplasms 2Neoplasm Metastasis 1

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × NVP-BKM120 × Genitourinary × Clear all
NCT01695473 2021-01-13

Neoadjuvant BKM120 in High-risk Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
11 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT01385293 2017-05-19

BKM120 in Metastatic Castration-resistant Prostate Cancer

Duke University

Phase 2 Terminated
30 enrolled 11 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡